<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02344264</url>
  </required_header>
  <id_info>
    <org_study_id>PROTOKOL - 001-2014 - KHTY</org_study_id>
    <secondary_id>2014-003730-10</secondary_id>
    <nct_id>NCT02344264</nct_id>
  </id_info>
  <brief_title>Effect of Nervus Cutaneous Femoris Lateralis-Blockade on Moderate Pain Responders After Total Hip Arthroplasty</brief_title>
  <official_title>Effect of Nervus Cutaneous Femoris Lateralis-Blockade on Moderate Pain Responders After Total Hip Arthroplasty</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Daniel Hägi-Pedersen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Naestved Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The patients will be included the 1. or 2. day after surgery. All THA patients will be
      screened. Those reporting VAS &gt; 40 during active 30 degrees hip flexion will be asked to
      participate.

      Included patients will receive 2xNCFL (singleshot) first placebo (8 ml saline) and then
      ropivacaine (8 ml ropivacaine 7,5mg/ml) or the other way around (randomized). There will be
      45 minutes between the two blockades. The blockades will be ultrasound guided.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2015</start_date>
  <completion_date type="Actual">September 2015</completion_date>
  <primary_completion_date type="Actual">September 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Difference in VAS between NCFL and placebo during active 30 degrees hip flexion</measure>
    <time_frame>45 min</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Difference in mean VAS between the groups during active hip flexion</measure>
    <time_frame>15, 30, 45, 60, 75, 90 min</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Difference in mean VAS between the groups at rest</measure>
    <time_frame>15, 30, 45, 60, 75, 90 min</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Pain, Postoperative</condition>
  <condition>Ropivacaine</condition>
  <condition>Therapeutic Use</condition>
  <condition>Arthroplasty, Replacement, Hip</condition>
  <arm_group>
    <arm_group_label>RP</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>first blockade: ropivacaine 7,5mg/ml 8 ml second blockade: placebo: saline 8 ml</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PR</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>first blockade: placebo: saline 8 ml second blockade: ropivacaine 7,5mg/ml 8 ml</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ropivacaine</intervention_name>
    <description>Arm RP is receiving 8 ml of ropivacaine 7,5 mg/ml at first blockade (NCFL) and after 45 minutes another blockade (NCFL) with placebo (saline 8ml).
Arm PR is receiving 8 ml of placebo (saline) at first blockade (NCFL) and after 45 minutes another blockade (NCFL) with ropivacaine 8 ml.</description>
    <arm_group_label>RP</arm_group_label>
    <arm_group_label>PR</arm_group_label>
    <other_name>Naropin</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Saline</intervention_name>
    <description>Arm RP is receiving 8 ml of ropivacaine 7,5 mg/ml at first blockade (NCFL) and after 45 minutes another blockade (NCFL) with placebo (saline 8ml).
Arm PR is receiving 8 ml of placebo (saline) at first blockade (NCFL) and after 45 minutes another blockade (NCFL) with ropivacaine 8 ml.</description>
    <arm_group_label>RP</arm_group_label>
    <arm_group_label>PR</arm_group_label>
    <other_name>NaCl</other_name>
    <other_name>Placebo</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  THA within 48 hours and VAS&gt;40 during active 30 degrees hip flexion despite
             conventional pain medication.

          -  informed consent

          -  ASA 1-3

          -  BMI 18-40

        Exclusion Criteria:

          -  Unable to communicate in danish

          -  Allergic reactions toward drugs used

          -  Abuse of alcohol/drugs

          -  Unable to cooperate

          -  Pregnant women
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Daniel Hägi-Pedersen, Ph.D.</last_name>
    <role>Study Chair</role>
    <affiliation>Naestved Hospital, Department of Anaesthesiology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Anaesthesiology</name>
      <address>
        <city>Næstved</city>
        <state>Danmark</state>
        <zip>4700</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>September 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 16, 2015</study_first_submitted>
  <study_first_submitted_qc>January 16, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 22, 2015</study_first_posted>
  <last_update_submitted>September 24, 2015</last_update_submitted>
  <last_update_submitted_qc>September 24, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 25, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Naestved Hospital</investigator_affiliation>
    <investigator_full_name>Daniel Hägi-Pedersen</investigator_full_name>
    <investigator_title>Consultant</investigator_title>
  </responsible_party>
  <keyword>US guided nerve block</keyword>
  <keyword>Total hip Arthroplasty</keyword>
  <keyword>NCFL</keyword>
  <keyword>nervus cutaneous femoralis lateralis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ropivacaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

